Skip to main content

Post MI: ACE inhibitor or ARB therapy

CBE ID
0594
1.4 Project
Cardiovascular
Endorsed
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
E&M Cycle
Full Year 2014
Is Under Review
No
1.3 Measure Description

This measure identifies patients with ST elevation MI (STEMI), or non-ST elevation MI (NSTEMI) plus a history of hypertension, heart failure and/or diabetes prior to the measurement year who are taking an ACEI or an ARB during the measurement year.

    • 1.14 Numerator

      Patients in the denominator with at least 1 Rx claim for an ACEI or an ARB medication during the measurement year

      Time Window: See below

    • 1.15 Denominator

      Patients with STEMI, or NSTEMI with hypertension, HF and/or diabetes, prior to the measurement year

      Tine Window: See below

    • Exclusions

      Excludes members who meet the following criteria for the ACE/ARB contraindication
      - >=1 claim with a diagnosis code for ´hyperkalemia´, ´renal artery stenosis´, ´ESRD´, ´severe chronic kidney disease´, ´pregnancy´, or ´angioneurotic edema´ (see below for the complete list of ICD9 codes)´

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Cardiovascular Project 2014-2015
      Initial Endorsement
      Last Updated
      Removal Date